Faculty

Institution

Unit

Venue

Arba Ager

Professor of Microbiology and Immunology

University of Miami

Affiliations

Miller School of Medicine

Microbiology and Immunology

The Graduate School

Arba Ager is currently serving as a Microbiology And Immunology Professor of Microbiology and Immunology at University of Miami.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Arba Ager

University of Miami

Professor of Microbiology and Immunology

You can click a keyword to filter the displayed items

pharmacology malaria infectious diseases tropical medicine medicine medicinal chemistry public health parasitology veterinary medicine clinical microbiology drug discovery nutrition avian medicine respiratory medicine antimalarial activity virology clinical nutrition public health nutrition animal nutrition mammalian biology nutrient physiology medical nutrition nutritional sciences antimicrobial agents infection control host-microbe interactions medical microbiology human nutrition antiparasitic agent antimalarial activities diagnosis applied microbiology medicinal research experimental medicine preventive medicine host-parasite relationships diagnostic microbiology diagnostic tests viral diagnostics herbal medicine derivative (chemistry) chloroquine-resistant malaria field evaluation vitamin e-deficient diet murine malaria san pedro sula imidazolidinedione derivatives malaria treatment antimalarial peroxides molecular cell biology cell metabolism cellular biology microbial physiology lipoprotein metabolism disease diagnosis dietary health treatment effects drug targeting clinical infectious disease nanotoxicology emerging infectious diseases disease detection anticoagulants secondary metabolism neuroprotection nutritional epidemiology microbial contamination arid environments clinical mycology disease transmission liver-stage malarial parasites key role optimal test rapid diagnosis indicator microbes cod-liver oil

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterization of the Mechanism of Resistance of the Aminomethylphenol, Jpc-3210 (Mmv892646). American Journal of Tropical Medicine and Hygiene (2018)

Marina ChavchichKarin van BredaJye TravisRowcliffe KerrynArba AgerGavin HeffernanGuy SchiehserLaura JacobusG. ShanksDavid JacobusMichael Edstein

tropical medicinedrug resistancemedicinepharmacologyhealth sciences

Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, Jpc-3210, for Malaria Treatment and Prevention. Antimicrobial Agents and Chemotherapy (2018)

Geoffrey W. BirrellGavin D. HeffernanGuy A. SchiehserJohn AndersonArba L. AgerPablo MoralesDonna MacKenzieKarin van BredaMarina ChavchichLaura R. JacobusG. Dennis ShanksDavid P. JacobusMichael D. Edstein

antimicrobial agentspreclinical pharmacologymalariapharmacologymalaria treatment

The Eif2α Kinase Heme-Regulated Inhibitor Protects the Host From Infection by Regulating Intracellular Pathogen Trafficking. Infection and Immunity (2018)

Wael BahnanJustin C. BoucherPetoria GayleNiraj ShresthaMark RosenBertal AktasBecky AdkinsArba AgerWasif N. KhanKurt Schesser

intracellular pathogen traffickinginfectious diseasesimmunologyheme homeostasisheme transporthematologyheme traffickingimmune responsespharmacologyheme signalingenzyme inhibitioninfection controlhost-microbe interactions

Lead Selection of a New Aminomethylphenol, Jpc-3210, for Malaria Treatment and Prevention. Antimicrobial Agents and Chemotherapy (2016)

Marina ChavchichGeoffrey W. BirrellArba L. AgerDonna O. MacKenzieGavin D. HeffernanGuy A. SchiehserLaura R. JacobusG. Dennis ShanksDavid P. JacobusMichael D. Edstein

antimicrobial agentsmalarialead selectionpharmacologymalaria treatment

A Targeted and Adjuvanted Nanoparticle for Immunochemotherapy of Leishmania Infections. Current Tropical Medicine Reports (2014)

Pirouz M. DaftarianArba L. AgerGeoffrey Stone

public healthtropical medicineinfectious diseasesnanoparticlesnanomedicinenanotechnologyrespiratory medicineimmunotherapyleishmania infectionsmedicineclinical researchadjuvanted nanoparticle

Jpc-2997, a New Aminomethylphenol With High in Vitro and in Vivo Antimalarial Activities Against Blood Stages of Plasmodium. Antimicrobial Agents and Chemotherapy (2014)

Geoffrey W. BirrellMarina ChavchichArba L. AgerHong-Ming ShiehGavin D. HeffernanWenyi ZhaoPeter E. KrasuckiKurt W. SaionzJacek TerpinskiGuy A. SchiehserLaura R. JacobusG. Dennis ShanksDavid P. JacobusMichael D. Edstein

antimicrobial agentsinfectious diseasesmalariaantiparasitic agentantimicrobial chemotherapyblood stagesmedicinepharmacology

A Targeted and Adjuvanted Nanocarrier Lowers the Effective Dose of Liposomal Amphotericin B and Enhances Adaptive Immunity in Murine Cutaneous Leishmaniasis. The Journal of Infectious Diseases (2013)

Pirouz M. DaftarianGeoffrey W. StoneLeticia KovalskiManoj KumarAram VosoughiMaitee UrbietaPat BlackwelderEmre DikiciPaolo SerafiniStephanie DuffortRichard BoodooAlhelí Rodríguez-CortésVance LemmonSapna DeoJordi AlberolaVictor L. PerezSylvia DaunertArba L. Ager

drug targetingimmunologynanotechnologymurine cutaneous leishmaniasisnanotoxicologyclinical microbiologyinfectious diseasesemerging infectious diseasesimmunity (medicine)treatment effectsinfection controlvirologynanomedicineparasitologymedicinal researchapplied microbiologyclinical infectious diseasemedicineexperimental medicineeffective dose

Chemotherapy of Cutaneous Leishmaniasis. (2012)

Arba Ager

infectious diseasesparasitologydermatologydermatological treatmenttreatment developmentcutaneous biologymedicinecutaneous leishmaniasisinfection control

Novel Diaryl Ureas With Efficacy in a Mouse Model of Malaria. Bioorganic & Medicinal Chemistry Letters (2012)

John W. AndersonDimitri SarantakisJacek TerpinskiT.R. Santha KumarHan-Chun TsaiMack KuoArba L. AgerWilliam R. JacobsGuy A. SchiehserSean EkinsJames C. SacchettiniDavid P. JacobusDavid A. FidockJoel S. Freundlich

mouse modelmalariamedicinal chemistrybioorganic chemistrymedicinepharmacologynovel diaryl ureasdrug discoveryurology

Antimalarial Activity of 9A- N Substituted 15-Membered Azalides With Improved in Vitro and in Vivo Activity Over Azithromycin. Journal of Medicinal Chemistry (2011)

Mihaela PerićAndrea FajdetićRenata RupčićSulejman AlihodžićDinko ŽiherMirjana Bukvić KrajačićKirsten S. SmithZrinka Ivezić-SchönfeldJasna PadovanGoran LandekDubravko JelićAntun HutinecMilan MesićArba AgerWilliam Y. EllisWilbur K. MilhousColin OhrtRadan Spaventi

antimalarial activitymedicinal chemistrymedicinepharmacologydrug discovery

1
2
3
4
5
6
10 / page

Arba Ager

Professor of Microbiology and Immunology

University of Miami

Affiliations

Miller School of Medicine

Microbiology and Immunology

The Graduate School

Arba Ager is currently serving as a Microbiology And Immunology Professor of Microbiology and Immunology at University of Miami.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Arba Ager

University of Miami

Professor of Microbiology and Immunology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterization of the Mechanism of Resistance of the Aminomethylphenol, Jpc-3210 (Mmv892646). American Journal of Tropical Medicine and Hygiene (2018)

Marina ChavchichKarin van BredaJye TravisRowcliffe KerrynArba AgerGavin HeffernanGuy SchiehserLaura JacobusG. ShanksDavid JacobusMichael Edstein

tropical medicinedrug resistancemedicinepharmacologyhealth sciences

Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, Jpc-3210, for Malaria Treatment and Prevention. Antimicrobial Agents and Chemotherapy (2018)

antimicrobial agentspreclinical pharmacologymalariapharmacologymalaria treatment

The Eif2α Kinase Heme-Regulated Inhibitor Protects the Host From Infection by Regulating Intracellular Pathogen Trafficking. Infection and Immunity (2018)

Wael BahnanJustin C. BoucherPetoria GayleNiraj ShresthaMark RosenBertal AktasBecky AdkinsArba AgerWasif N. KhanKurt Schesser

Lead Selection of a New Aminomethylphenol, Jpc-3210, for Malaria Treatment and Prevention. Antimicrobial Agents and Chemotherapy (2016)

Marina ChavchichGeoffrey W. BirrellArba L. AgerDonna O. MacKenzieGavin D. HeffernanGuy A. SchiehserLaura R. JacobusG. Dennis ShanksDavid P. JacobusMichael D. Edstein

antimicrobial agentsmalarialead selectionpharmacologymalaria treatment

A Targeted and Adjuvanted Nanoparticle for Immunochemotherapy of Leishmania Infections. Current Tropical Medicine Reports (2014)

Pirouz M. DaftarianArba L. AgerGeoffrey Stone

public healthtropical medicineinfectious diseasesnanoparticlesnanomedicinenanotechnologyrespiratory medicineimmunotherapyleishmania infectionsmedicineclinical researchadjuvanted nanoparticle

Jpc-2997, a New Aminomethylphenol With High in Vitro and in Vivo Antimalarial Activities Against Blood Stages of Plasmodium. Antimicrobial Agents and Chemotherapy (2014)

antimicrobial agentsinfectious diseasesmalariaantiparasitic agentantimicrobial chemotherapyblood stagesmedicinepharmacology

Chemotherapy of Cutaneous Leishmaniasis. (2012)

Arba Ager

infectious diseasesparasitologydermatologydermatological treatmenttreatment developmentcutaneous biologymedicinecutaneous leishmaniasisinfection control

Novel Diaryl Ureas With Efficacy in a Mouse Model of Malaria. Bioorganic & Medicinal Chemistry Letters (2012)

mouse modelmalariamedicinal chemistrybioorganic chemistrymedicinepharmacologynovel diaryl ureasdrug discoveryurology

Antimalarial Activity of 9A- N Substituted 15-Membered Azalides With Improved in Vitro and in Vivo Activity Over Azithromycin. Journal of Medicinal Chemistry (2011)

antimalarial activitymedicinal chemistrymedicinepharmacologydrug discovery

1
2
3
4
5
6
10 / page

Similar Faculty Members

Ian Carroll

Institution

University of North Carolina at Chapel Hill

health science

dysbiosis

Ana M. Rodriguez

Institution

New York University

infectious diseases (medical specialty)

malaria

Melinda Beck

Institution

University of North Carolina at Chapel Hill

neglected tropical disease

host response

Lars Bode

Institution

University of California, San Diego

human milk

health science

Dennis Kyle

Institution

University of Georgia

parasite control

neglected tropical disease

Volker Mai

Institution

University of Florida

metagenomics

dysbiosis

Simin Nikbin Meydani

Institution

Tufts University

immunology

health sciences

Judd Walson

Institution

Johns Hopkins University

public health

global health

Shirish Barve

Institution

University of Louisville

pharmacology

hepatology

Aaron Ericsson

Institution

University of Missouri

fetal programming

dysbiosis

Similar Faculty Members

Ian Carroll

Institution

University of North Carolina at Chapel Hill

health science

dysbiosis

Ana M. Rodriguez

Institution

New York University

infectious diseases (medical specialty)

malaria

Melinda Beck

Institution

University of North Carolina at Chapel Hill

neglected tropical disease

host response

Lars Bode

Institution

University of California, San Diego

human milk

health science

Dennis Kyle

Institution

University of Georgia

parasite control

neglected tropical disease

Volker Mai

Institution

University of Florida

metagenomics

dysbiosis

Simin Nikbin Meydani

Institution

Tufts University

immunology

health sciences

Judd Walson

Institution

Johns Hopkins University

public health

global health

Shirish Barve

Institution

University of Louisville

pharmacology

hepatology

Aaron Ericsson

Institution

University of Missouri

fetal programming

dysbiosis